Zacks Small Cap Raises Earnings Estimates for Spectral AI

Spectral AI, Inc. (NASDAQ:MDAI) – Research analysts at Zacks Small Cap upped their FY2025 earnings per share estimates for Spectral AI in a report released on Wednesday, April 2nd. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will earn ($0.45) per share for the year, up from their previous forecast of ($0.57). The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share. Zacks Small Cap also issued estimates for Spectral AI’s FY2026 earnings at ($0.18) EPS and FY2026 earnings at ($0.18) EPS.

Spectral AI (NASDAQ:MDAI) last announced its quarterly earnings data on Thursday, March 27th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.07. The firm had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.83 million.

Separately, HC Wainwright reiterated a “buy” rating and set a $3.50 price objective on shares of Spectral AI in a research note on Wednesday.

Spectral AI Stock Performance

Spectral AI stock opened at $1.21 on Friday. Spectral AI has a 1 year low of $0.82 and a 1 year high of $3.25. The firm’s 50-day moving average is $1.69 and its 200-day moving average is $1.67. The company has a market cap of $28.13 million, a P/E ratio of -1.86 and a beta of 0.62.

Institutional Investors Weigh In On Spectral AI

A number of hedge funds have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC bought a new position in shares of Spectral AI during the fourth quarter worth about $272,000. Avantax Planning Partners Inc. boosted its stake in Spectral AI by 44.7% during the 4th quarter. Avantax Planning Partners Inc. now owns 231,336 shares of the company’s stock valued at $655,000 after purchasing an additional 71,484 shares during the period. Jane Street Group LLC bought a new position in Spectral AI in the 4th quarter worth about $92,000. Millington Financial Advisors LLC acquired a new stake in shares of Spectral AI in the fourth quarter valued at approximately $85,000. Finally, Northern Trust Corp bought a new stake in shares of Spectral AI during the fourth quarter valued at approximately $44,000. 67.08% of the stock is currently owned by institutional investors.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.